Add to ORKGDo smoking cessation therapies (nicotine replacement therapy [NRT], bupropion, and varenicline) increase risk for cardiovascular (CV) events? Review scope Included studies assessed NRT (any marketed dose or combination) or licensed doses of bupropion or varenicline for any duration as cessation therapy in smokers and reported CVD events. Outcomes were any CV event and major adverse CV events (MACE) (CV death, nonfatal myocardial infarction, and nonfatal stroke)
ObjectiveTo examine the risk of treatment emergent, cardiovascular serious adverse events associated...
SummaryBackgroundVarenicline is an effective pharmacotherapy to aid smoking cessation. However, its ...
Background: Schizophrenic patients have a lot higher smoking rates when compared to people in the ge...
Smoking continues to be the leading cause of preventable deaths in the USA, accounting for one in ev...
Smoking continues to be the leading cause of preventable deaths in the USA, accounting for one in ev...
ImportanceQuitting smoking is enhanced by the use of pharmacotherapies, but concerns have been raise...
Cigarette smoking continues to be the leading cause of preventable death and is the main risk factor...
Inform patients who are interested in taking varenicline (Chantix) that there is a small cardiovascu...
Background Smoking is a main cause of early death throughout the world. There are a number of medi...
Abstract: Cigarette smoking remains an important risk factor for premature cardiovascular disease an...
Smoking cessation lowers the risk of death substantially in patients with cardiovascular disease. Al...
Cigarette smoking is a major risk factor for cardiovascular disease (CVD) and the leading avoidable ...
AbstractThis review discusses the known cardiovascular effects of smoking and the effects of nicotin...
Background: Smoking is the leading cause of preventable death worldwide. Although smoking cessation ...
INTRODUCTION: Cigarette smoking is one of the leading causes of early death in the UK and worldwide....
ObjectiveTo examine the risk of treatment emergent, cardiovascular serious adverse events associated...
SummaryBackgroundVarenicline is an effective pharmacotherapy to aid smoking cessation. However, its ...
Background: Schizophrenic patients have a lot higher smoking rates when compared to people in the ge...
Smoking continues to be the leading cause of preventable deaths in the USA, accounting for one in ev...
Smoking continues to be the leading cause of preventable deaths in the USA, accounting for one in ev...
ImportanceQuitting smoking is enhanced by the use of pharmacotherapies, but concerns have been raise...
Cigarette smoking continues to be the leading cause of preventable death and is the main risk factor...
Inform patients who are interested in taking varenicline (Chantix) that there is a small cardiovascu...
Background Smoking is a main cause of early death throughout the world. There are a number of medi...
Abstract: Cigarette smoking remains an important risk factor for premature cardiovascular disease an...
Smoking cessation lowers the risk of death substantially in patients with cardiovascular disease. Al...
Cigarette smoking is a major risk factor for cardiovascular disease (CVD) and the leading avoidable ...
AbstractThis review discusses the known cardiovascular effects of smoking and the effects of nicotin...
Background: Smoking is the leading cause of preventable death worldwide. Although smoking cessation ...
INTRODUCTION: Cigarette smoking is one of the leading causes of early death in the UK and worldwide....
ObjectiveTo examine the risk of treatment emergent, cardiovascular serious adverse events associated...
SummaryBackgroundVarenicline is an effective pharmacotherapy to aid smoking cessation. However, its ...
Background: Schizophrenic patients have a lot higher smoking rates when compared to people in the ge...